FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

AbbVie Urges FDA to Ban Unlicensed Thyroid Products

AbbVie petitions FDA urging it to crack down on newly introduced unlicensed desiccated thyroid extract products.

latest-news-card-1
Federal Register

FDA Seeks Industry Rep for Device Panel

Federal Register notice: FDA seeks industry organizations interested in participating in selecting a nonvoting industry representative to serve on CDR...

latest-news-card-1
Federal Register

Panel to Discuss Pediatric Studies for Cancer Drugs

Federal Register notice: FDA announces a 5/22 Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee meeting to discuss requirement...

latest-news-card-1
Medical Devices

Withdraw AvertD Approval: Scientists

Some 31 experts in genetics, addiction, psychiatry, and medical devices call on FDA to revoke its approval of the AvertD DNA test that claims to predi...

latest-news-card-1
Medical Devices

45 CDRH Safety Communications in 2022: Report

In a delayed report to Congress, CDRH says it issued 45 medical device safety communications of various types in 2022.

latest-news-card-1
Medical Devices

Medos Guide Sheath Recall is Class 1: FDA

FDA says the Medos International Srl recall of the Cerenovus Cerebase DA guide sheath is Class 1.

latest-news-card-1
Human Drugs

Liquidia Expects FDA Yutrepia Final OK Soon

Liquidia says it believes there no longer are legal bars on FDA approving its Yutrepia inhalation powder for two indications.

latest-news-card-1
Human Drugs

Novartis Seeking Expanded Pluvicto Label

Novartis says it will seek FDA approval for an expanded use for Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for slowing disease progression in pa...

latest-news-card-1

FDA Cross-Center AI Paper Analyzed

Hogan Lovells attorneys say FDA may create new Centers of Excellence as it works to regulate AI in medical product development through cross-Center co...

latest-news-card-1
FDA General

Califf in Hot Seat at 4/11 Oversight Hearing

The House Committee on Oversight and Accountability ratchets up political pressure on FDA by requesting commissioner Robert Califfs testimony at a 4/1...